πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8658664

Cyclopamine tartrate salt and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8658778

hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8658168

Compositions and methods for homoconjugates of antibodies which induce growth arrest of ap

The Board of Regents of the University of Texas System Β· Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8652366

Aerosol-mediated particle synthesis

The Board of Regents of the University of Texas System Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8653243

Pertussis antibodies and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8653034

Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives

The Board of Regents of the University of Texas System Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8648102

Compounds for treatment of cell proliferative diseases

The Board of Regents of the University of Texas System Β· Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8647637

Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circu

The Board of Regents for Oklahoma State University Β· Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637675

Inhibitors of proliferation and activation of signal transducer and activators of transcri

The Board of Regents of the University of Texas System Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637503

Phenothiazine enantiomers as agents for the prevention of bone loss

The Board of Regents of the University of Texas System Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8632510

Nanochanneled device and related methods

The Board of Regents of the University of Texas System Β· Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8633154

Cyclodepsipeptides with antineoplastic activity and methods of using to inhibit cancer and

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8629119

Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders

The Board of Regents of the University of Texas System Β· Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8628917

Genes of an otitis media isolate of nontypeable Haemophilus influenzae

The Board of Regents of the University of Oklahoma Β· Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8623832

Peptide compositions that bind TLR-4

The Board of Regents of the University of Oklahoma Β· Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8617549

Bispecific nanobodies as a therapeutic for alzheimer's disease

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8618324

Composition and method for making oligo-benzamide compounds

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8618167

Methods of attenuating cognitive deficits with sulfonyl fluorides

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8618074

GPCR enhanced neuroprotection to treat brain injury

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8617538

Mesodermal-like cell population for treating ischemia in mammals

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8614082

Attenuation of encephalitogenic alphavirus and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8613944

Compositions and methods for separating tissue

The Board of Regents of the University of Texas System Β· Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8609404

Vaccines containing canine parvovirus genetic variants

The Board of Regents for Oklahoma State University Β· Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8609067

Method of measuring propulsion in lymphatic structures

The Board of Regents of the University of Texas System Β· Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted